NCT00392379View on ClinicalTrials.gov

Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction

PHASE3CompletedINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Smokeless Tobacco Use

Interventions

DRUG

Nicotine Lozenges

Nicotine lozenges, 4 mg

DRUG

Placebo lozenge

Placebo lozenge

Trial Locations (2)

55905

Mayo Clinic, Rochester

97403

Oregon Research Institute, Eugene

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER